We scan new podcasts and send you the top 5 insights daily.
A comprehensive go-to-market plan requires more than direct sales or GPO contracts. Companies must develop specific approaches for different channels, including direct contracting with Integrated Delivery Networks (IDNs), using distributors for fragmented markets like ASCs, and forming strategic partnerships.
Channel strategy shouldn't be reactive. Leaders must define their ideal partner ecosystem for 3-5 years out and proactively build towards it. This requires a vision-led approach and a willingness to stop servicing legacy models that don't fit the future.
To scale into the long tail of mid-market partners, arm distributors with a 'better together' narrative. Instead of a standalone product pitch, they should explain how your offering enhances solutions partners already sell, making the conversation more relevant and scalable.
The path to market is unpredictable. For startup Equal, the private market was initially sluggish while NHS contracts provided early revenue. Later, the private market accelerated. Pursuing different verticals with varying sales cycles creates a more stable, 'continual drip' of revenue.
Gaining FDA approval is not the finish line. Many innovative devices fail because they lack a clear reimbursement strategy. Founders must build the economic case for payers and providers in concert with their clinical and regulatory strategy from day one.
Emerging MedTech companies often view Group Purchasing Organization (GPO) agreements as a silver bullet for market access. However, these contracts require significant post-agreement effort and may be more effective as a later-stage strategy after a company has established itself through other channels.
Disruptive MedTech ideas attract investment, but they are high-risk. Founders should de-risk these big bets by developing market access and commercial strategies simultaneously with product development, not after FDA approval.
Many organizations mistakenly view partner marketing as a series of disconnected activities like webinars. True partner marketing is a comprehensive go-to-market strategy that defines the end-to-end plan for launching joint solutions and messages.
Eliminate separate distribution managers. By making Channel Managers responsible for the entire ecosystem—from distributors to partners—you ensure a consistent message and strategy, avoiding the information decay common in tiered channel models.
In a B2B supplier or distributor model, success depends on going downstream. You must understand not only your direct partner's business drivers and KPIs but also the needs of their end-customer. This allows you to align strategy across the entire value chain.
To break into slow-moving hospitals, Aegis initially targeted smaller, more agile medical billing companies that serve them. This strategy builds a proven product and case studies with customers who have a direct need and faster sales cycles, creating a powerful entry point to the larger hospital systems.